In most patients, coronary atherosclerosis or congestive heart failure develop as an integrated response to multiple cardiovascular risk factors. Obesity increases the prevalence of most cardiovascular risk factors and is the predominant cause of diabetes mellitus and arterial hypertension. Moreover, obesity shifts the manifestation of these risk factors to younger age groups, such that subsequent damage results prematurely in clinically overt cardiac diseases. In addition, due to clustering of obesity-related risk factors, obesity may amplify the risk by synergistic mechanisms acting in parallel. Finally, an elevated body mass index (BMI) results in an increase in heart rate and blood volume, as well as increased systolic and diastolic blood pressure. These changes affect cardiac geometry and mass in addition to the alterations of the coronary vasculature. At the population level, the role of obesity in promoting multiple risk factors and, subsequently, the development of heart diseases cannot be underestimated. In individual patients, however, the clinical presentation may be dominated by obesity-related hypertension, diabetes, metabolic and inflammatory derangements or clinical symptoms of heart failure or coronary artery disease. Weight reduction remains a crucial component of the therapeutic strategy to ameliorate insulin resistance, hypertension and left ventricular hypertrophy, among other risk factors, with profound implications for the individual's prognosis.
Introduction
The manifestation of coronary atherosclerosis and congestive heart failure results from long-term exposure of the heart to cardiovascular risk factors. The Framingham Heart Study showed that hypertension, diabetes mellitus and left ventricular hypertrophy, in addition to coronary heart disease, account for more than 90% of the (population attributable) risk for the development of congestive heart failure. 1 The same factors together with hypercholesterolaemia, chronic inflammation, smoking and genetic predisposition determine the risk for the premature development of coronary artery disease. Obesity is related to most, if not all, of these cardiovascular risk factors. Indeed, obesity has been shown to induce multiple risk factors, to result in early manifestation of these risk factors, and to cluster risk factors with more than additive effects on subsequent signs of cardiac diseases. 2 Currently, the burden of obesity-related disease may be best visualized by the horrendous economic burden associated with this condition. Colditz has estimated that nationwide costs of US$70 billion (9.4% of health care expenditure) are directly related to obesity in the United States. 3 Likewise, Quesenberry et al from the Kaiser Permanente Research Department estimated that individuals with a body mass index (BMI)>35 kg=m 2 contribute 44% higher mean annual health care costs compared with individuals with a normal BMI. Notably, the association between BMI and coronary heart disease, hypertension and diabetes largely explained these elevated costs. 4 
Obesity induces multiple risk factors
In Western societies, the degree of obesity is related to a stepwise increase in the prevalence of many risk factors. Figure 1 demonstrates the percentage of individuals with type 2 diabetes mellitus in the NHANES III study according to BMI classification. 5 In men with morbid obesity, the risk was five-times higher compared with individuals with normal weight. Similar data have been observed in the IOWA Women's Health Study, in which women in the highest quintile of BMI and waist-to-hip ratio had a relative risk of 29 for development of diabetes mellitus over a 12 y follow-up period. 6 The importance of obesity in precipitating insulin resistance is even more profound. 7 Indeed, obesity is associated with impaired glucose tolerance in more than 20% of overweight children or young adults.
Similarly, obesity increases the prevalence of arterial hypertension substantially, as shown in Figure 2 for the NHANES population. It has been estimated that 50% of all cases of arterial hypertension are secondary to obesity. 8 In respect to the incidence of hypertension, the Framingham Heart Study documented that a weight gain of 5% increases the risk of hypertension by 30% in a four-year period. 9 Specifically, stimulated sympathetic outflow and an inappropriately activated renin -angiotensin system have been identified as characteristic features in obese hypertensive patients. 10 In parallel to these neurohormonal mechanisms that may induce peripheral vasoconstriction and volume retention, obesity is characterized by a hyperdynamic circulation that may further increase blood pressure levels. Likewise, blood viscosity is elevated in obese patients due to an increased haematocrit level as well as elevated fibrinogen levels, which add to the pressure load on the heart.
11
Dyslipidaemia is also increased by obesity. In particular, obesity is characterized by a slightly increased prevalence of hypertriglyceridaemia, together with elevated total cholesterol as well as decreased HDL cholesterol levels 12, 13 ( Figure 3 ). Clinically more relevant may be the fact that these lipoproteins are characterized by abnormal physicochemical properties. Small dense LDL particles are increased in obese subjects and may confer an increased risk of coronary atherosclerosis.
14 Such LDL particles accumulate after conversion of VLDL remnants into the precursors of small, dense LDL by the action of hepatic lipase. Oxidative stress may further damage small dense LDL particles. Such oxidized LDL may bind to scavenger receptors located on the surface of macrophages that facilitate the influx of these lipoproteins with resultant foam cell-formation and local inflammation in the vascular wall. 2 HDL particles are the most important component in reverse cholesterol transport. HDL helps to remove cholesterol deposits from the vascular wall. Obesity and the metabolic syndrome are associated with low HDL levels ( Figure 3 ) and in addition, obesity is associated with a small HDL particle size that may add to the atherogenic profile in these patients. 15 Moreover, increased levels of plasma triglycerides are found in obese patients, a feature that may be unmasked specifically after a meal. 16 In addition to these traditional risk factors, obesity is related to more recently characterized putative risk factors such as inflammatory and thrombogenic markers. Most notably, lipoprotein(a), C-reactive protein, interleukin-6, fibrinogen, plasminogen-activator-inhibitor 1 (PAI-1) levels, to name just a few, are closely related with body fat mass and are markedly elevated in most patients with obesity.
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Early manifestation of obesity-related risk factors
The rapidly growing prevalence of obesity in children or young adults may be of particular concern since this phenomenon may facilitate early-life programming of cardiovascular risk factors. In this respect, it has been demonstrated that most overweight children become obese adults. 22 Indeed, childhood overweight has been shown to produce an adverse risk factor profile during adulthood. 21 -23 Subsequently, the critical duration of exposure to these risk factors may accumulate at an earlier time point, resulting in premature signs of cardiovascular disease. In fact, individuals aged 25 -35 y, with obesity-related signs of type 2 diabetes mellitus will probably not escape the consequences of longterm diabetes-related vascular or cardiac damage. Figure 3 The prevalence of decreased high-density lipoprotein cholesterol concentrations (<0.9 mmol=l) and elevated total cholesterol concentration (>6.5 mmol=l) in men and women with various degrees of waist circumference (cm) enlargement. Source: Han et al. 14 
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Obesity is related to clustering of risk factors
Obesity precipitates a variety of risk factors in parallel. In combination, these risk factors may potentiate their maladaptive changes in the myocardium as well as the coronary vasculature. The cluster of risk factors that is best documented is the metabolic syndrome. This term describes the co-existence of impaired glucose tolerance, insulin resistance, dyslipidaemia, hypertension, coagulation abnormalities and upper body obesity. By definition, a metabolic syndrome is a cluster of at least two of these comorbidities, in addition to elevated truncal fat mass. By affecting synergistically multiple mechanisms that all lead to premature atherosclerosis, individuals with the metabolic syndrome are characterized by a substantially increased risk for cardiovascular events. Figure 4 demonstrates the synergistic action of cardiovascular risk factors in mediating cardiovascular events as determined by the Framingham Heart Study. This illustration is, for the purpose of the present review, modified by adding the relative importance of obesity for the development of such risk factors.
Left ventricular hypertrophy
Like the coronary vasculature, obesity affects the cardiac muscle by multiple haemodynamic, metabolic and inflammatory alterations that may ultimately cause systolic or diastolic heart failure. Most notably, the heart of obese individuals is subjected to continued pressure overload. Specifically, obesity-related arterial hypertension 5 as well as elevated viscosity of the blood 24 have been shown to stimulate the growth of cardiac walls and, subsequently, induce concentric left ventricular hypertrophy (LVH). 25 In the absence of hypertension, the heart may also be damaged under these circumstances by chronic volumeoverload due to an elevated cardiac output. 25 
Cardiac function and obesity
Both concentric and eccentric LVH have been shown to increase the risk of systolic as well as diastolic dysfunction of the heart. 29 Most prominently, chronic elevation of cardiac pressure load and secondary concentric LVH result in a progressive impairment of LV filling and, subsequently, diastolic heart failure. Accordingly, obesity has been identified as an independent predictor of LV diastolic dysfunction in the general population. 30 With excessive obesity, alterations in systolic function may be most evident. 31 In particular, longstanding obesity may result in a decrease in mid wall fibre shortening and ejection fraction. 31, 32 In conjunction, diastolic and systolic malfunction of the heart together with obesity itself contribute to the profound symptomatology of such individuals, most notably dyspnoea and reduced exercise capacity.
Not surprisingly, obesity has been identified as a major factor in the development of congestive heart failure. Most recently, the NHANES I investigators demonstrated that the obesity-related population-attributable risk of symptomatic heart failure is 8%. 33 This is in addition to the indirect effects of obesity mediated by coronary artery disease (population attributable risk 61.6%), hypertension (population attributable risk 10.1%), diabetes (population attributable risk 3.1%) and low physical activity (population attributable risk 9.2%). 33 Thus, with respect to the development of congestive heart failure, obesity is interrelated with a multitude of precipitating factors, that may, in addition to their individually mediated risk be overwhelmingly powerful when clustered in individuals with severe overweight (Figure 4 ). 
Cardiac arrhythmias and obesity
In addition to changes in cardiac function, cardiac arrhythmias are frequently found in obese subjects. Particularly, with a concentric pattern of LVH, the prevalence of ventricular ectopic beats is substantially elevated. 34 Moreover, obesity is a significant risk factor for atrial fibrillation. 35 In this respect, the hyperdynamic circulation in conjunction with diastolic dysfunction, as observed in obesity, may constitute important pathophysiological mechanisms. In addition to the related symptoms, these arrhythmias may also contribute to the elevated cardiovascular risk as observed in obese individuals. 34 
Cardiac mortality and obesity
A number of studies have clearly demonstrated that a BMI above 30 kg=m 2 dramatically increases cardiac mortality. 36 There has been a long-standing debate as to whether such an increase is independently mediated by obesity or indirectly conferred by associated risk factors. In a chain of events that starts with obesity, subsequently results in diabetes mellitus or arterial hypertension together with other risk factors and finally ends with adverse cardiac events, it may be difficult to identify the initiating force by statistical evaluation. 37 In fact, multivariate regression analysis may produce the false impression that the effect of obesity is rather small.
Long-term epidemiological studies such as the Framingham Heart Study may be of particular advantage to delineating the events that ultimately result in cardiovascular disease. In this respect, Hubert and coworkers clearly demonstrated that obesity is an independent risk factor for cardiovascular disease and in particular, sudden cardiac death during 26 y of follow-up. 38 Similar data were obtained in the Nurses Health Study, which investigated cardiovascular events in 115 195 women during a follow-up of 16 y. 39 In a multivariate analysis, a BMI > 29 kg=m 2 was associated with a relative risk of 2.1 for all-cause mortality and 4.6 for death from coronary heart disease. This relative risk increased to 5.8 in women with a BMI of 32 kg=m 2 who had never smoked. 39 Similar results were obtained in 12 000 men and women from the Copenhagen Heart Study, in which obesity by itself ranked in the fourth position with respect to the population-attributable risk of coronary heart disease. 40 Finally, recent evidence indicates that obesity, even in the absence of concomitant coronary risk factors, independently increases the risk of cardiovascular disease. 40, 41 Weight loss and prognosis Weight loss has been shown to decrease in parallel the burden of multiple risk factors. 42 For example, successful completion of a diet programme may decrease systolic and diastolic blood pressure by 8 and 6 mmHg, respectively. 43 In other words, weight-reduction by 1 kg lowers both systolic and diastolic blood pressure by 1 mmHg on average. 44 Similarly, recent studies clearly demonstrate the overwhelming reduction in the incidence of diabetes mellitus by intensive weight-loss programmes. 45 Moreover, diet is the central factor in all guidelines on the treatment of hypercholesterolaemia and hypertriglyceridaemia. In addition to the effects on traditional risk factors, weight loss has substantial implications on the elevated levels of C-reactive protein as well as a whole series of inflammatory and pro-coagulant factors, cytokines and adhesion molecules. 44 In addition to the beneficial effects on coronary risk, weight loss has substantial implications for the regression of left ventricular hypertrophy in obese patients. 43 Indeed, diet has been documented to be at least as effective as aggressive antihypertensive medication in normalization of the elevated left ventricular mass. 43 Moreover, Zannad and co-workers demonstrated that sibutramineassisted weight-loss has beneficial effects on the prevalence of left ventricular hypertrophy in obese individuals 46 ( Figure 5 ). Finally, weight reduction may reduce heart rate variability and serve as an indicator of less arrhythmogenic events after the successful completion of a diet program. 47 
Conclusion
The heart and coronary vasculature of obese individuals are subjected to a multitude of coronary risk factors as well as haemodynamic alterations that, in conjunction, increase the risk of a variety of cardiac diseases. Depending on the range of contributing factors, symptoms of either coronary heart disease or congestive heart failure may dominate the clinical presentation. Ultimately, myocardial infarction or cardiac arrhythmias may develop, both increasing the risk of sudden cardiac death. Consequently, great emphasis should be directed towards weight reduction for prevention of cardiac alterations secondary to obesity. Unfortunately, at the present time, the frequent failure to treat obesity is a missed opportunity to modify cardiovascular risk by optimal physician counselling. 48 
